The U.S. Ambassador to Norway Samuel D Heins visited The Intervention Centre with a delegation from U.S: Commercial Service at the Embassy of the United States of America and representatives from Oslo Medtech. The ambassador was shown the high tech hybrid operating rooms at the Centre, and tried the HoloLens preoperative surgical planning system under development in a project between Microsoft, Sopra Steria and The Intervention Centre. Ambassador Heins expressed an ambition to support collaboration between Amarican and Norwegian actors within healthcare. The U.S. Commercial Service at the United States of America Department of Commerce works actively to strengthen trade and commercial activites between the two countries.
Surgeons and technology experts at the Intervention Centre collaborate with programmers and experts from the consulting firm Sopra Steria in a project for 3D guided imaging displayed on the HoloLens platform from Microsoft. A system for pre-operative surgical planning and intra-operative navigation developed by researchers at The Intervention Centre has been implemented on HoloLens. On the image professor Bjørn Edwin assesses a virtual segmented 3D liver hologram with vessels and the central cancer tumor. The early phase project result was presented in the evening news by the national Norwegian broadcaster NRK. The project goal is to continue to develop the system and evaluate potential clinical applications.
The Intervention Centre at Oslo University Hospital, Rikshospitalet is granted approximately NOK 40 mill. for the project HiPerNav (High Performance Soft-tissue Navigation). The project, that will be running for 4 years, is coordinated by Ole Jakob Elle head of Technology Research at The Intervention Centre and associate professor at Department of Informatics, University of Oslo. The consortium consists of 14 participating organisations from leading European universities, hospitals and industry which through the education of 16 PhD’s will develop the navigation systems of the future for the improvement of liver surgery. In addition to Oslo University Hospital which coordinate the project, Sintef and NTNU is project partners on the Norwegian side. The other European beneficiaries and partner organisations are University of Bern, Cascination, Inselspital-Stiftung, University of Delft, University of Cordoba, University Paris 13, INRIA, Siemens, NVIDIA, Innovasjon Norge and Yes!Delft. The project will develop new technological solutions that intend to simplify and improve accuracy in surgical navigation, which will be clinically validated at The Intervention Centre by surgeon Bjørn Edwin and at the hospital Inselspital-Stiftung in Bern. NorMIT’s research platform for surgical navigation, financed through the Large-Scale Research Infrastructure funding from the Norwegian Research Council, will be used in parallel with the integration of the new methods into a clinical product through the industrial partner Cascination. Picture: HiPerNav coordinator Assosciate Professor Ole Jakob Elle flanked by Professor Per Kristian Hol (left) and Professor Bjørn Edwin (right)
The 1st HealthInsight open workshop takes place on May 20th 2016 from 9:00-16:00, at Institute of Informatics, University of Oslo, Ole Johan Dahls hus, 5th floor (room 5462), Informatikksalen. HealthInsight is a program accepted by Research Council of Norway for seed funding. This workshop is a project kick-off with the purpose of bringing together key stakeholders and other interested parties to discuss steps to advance Norway’s use of Big Data technologies in healthcare. Please see the program for further details. Purpose of the workshop: Bring together the community to meet and discuss steps to advance Norway’s use of healthcare big data. All interested participants are welcome! Place Registration for participation in the Workshop in Nettskjema
The BigMed project has received 60 million NOK in funding from the Research Council of Norway IKTPLUSS Lighthouse program. Jan Rasmus Sulebak (right side on picture, Erik Fosse left side) presented the winners at the eHEALTH 2016 event. For one year ago it was more than 70 interested parties to participate in the IKTPLUSS program, and finally only three were awarded funding.
The vision behind the BIG data MEDical solution (BIGMED) is to lay the foundation for an ICT platform that addresses the analytic bottlenecks for the implementation of precision medicine, and paves the way for novel big data analytics. The solutions will provide the patients with an optimized care which takes their unique individual characteristics into proper consideration.
We have selected four patient groups in focus in the project;patients with lung cancer, colorectal cancer, sudden cardiac death and monogenic diseases. The BigMed consortium includes patient organisations, academic- and industrial partners. Patient organiation partners are Kreftforeningen, Landsforeningen for hjerte- og lungesyke and Foreningen for hjertesyke barn. Industrial partners are DNV GL, Sykehuspartner HF, IBM World Trade Corporation, Pubgene AS, Kunnskapsforlaget ANS, DIPS ASA, Karolinska Institutet and Oslo Medtech NCE. Clinical partners are Oslo University Hospital (The Intervention Centre, Department of Oncology, Department of Molecular Pathology, Department of Medical Genetics, Department of Cardiology), Norwegian Armed Forces Joint Medical Service and Oslo Center for Biostatistics and Epidemiology. Academic partners from University of Oslo are Department of Informatics and The University Center for Information Technology. From NTNU Department of Computer and Information Science.
On April 12th 2016 the Norwegian Minister of Health Bent Høie visited The Intervention Centre. The Minister spent nearly two hours in the Operating Room area at the Centre and guided by professor Erik Fosse and CEO of the Oslo University Hospital Acute Clinic Øyvind Skraastad he watched three different ongoing minimally invasive procedures; laparoscopic pancreas surgery, MRI guided neuro-surgery and an endovascular aneurism repair (EVAR) procedure. In the picture radiologists and surgeons demonstrates aortic grafts used in invasive radiology procedures. See more @InterventionCen on Twitter.
Dr. Kyrre Eeg-Emblem, researcher at The Intervention Centre, has been awarded the Fridtjof Nansen award for young researchers for outstanding contributions in medical diagnostics from the Nansen Fund. The Fridtjof Nansen award is given to young researcher under 40 years with a permanent address in Norway. The price is 100.000 KOK and a diploma. The award is shared with Magne Mogstad. The award will be handed out at the general assembly of the Norwegian Academy of Science in the beginning of May 2016.
The Intervention Centre hosts part of a course for Gastroenterology
Surgeons at Oslo University Hospital in April 2016. Parts of the clinical
training will take place at the centre, and the program for the course
has been made available at The Intervention Centre web page. Se the
program here: Surgical Gastroenterology Course Program. The program contains downloadable articles and videos from many of the presenters.
On March 1st 2016 Stefan Hyler, MD defended his thesis on Microsensors allow continuous monitoring of myocardial ischemia in cardiac surgery at Institute of Clinical Medicine, University of Oslo. 1.opponent was Professor Anders Jeppsson,Thoraxkirurgisk avdeling,Sahlgrenska akademin, Gøteborgs Universitet, Sweden, 2.opponent: Overlege Ole Magnus Filseth, Akuttmedisinsk klinikk, Universitetssykehuset i Nord-Norge, 3. memember of committe: Førsteamanuensis Kristin Bjørnland, Institutt for klinisk medisin, Universitetet i Oslo, Norge. Image (from left): professor Anders Jeppson, main superviser Steinar Halvorsen MD, PhD, Ole Magnus Filseth MD, Stefan Hyler, MD, PhD and professor Erik Fosse, co-supervisor.
Three OUS researchers have been accepted as members: Gro Elisabeth Lind, head of the Epigentics group at the Department of Molecular Oncology at the Institute for Cancer Research, Kyrre Eeg Emplem, principal investigator in Atle Bjørnerud's Functional MR Neuroimaging group at the Intervention Centre and Monica Aas from Ingrid Melle's group at the Division of Mental Health & Addiction.
On September 16th 2015 Karl Øyri defended his thesis on Feasibility of short-range wireless monitoring in critical care environments. Background: Feasibility of patient monitoring in critical care based on short-range wireless technologies still is an open question. Despite wide penetration of the consumer market, short-range wireless technologies still are not widely implemented in clinical practice. Short-range wireless radio links, with air-based propagation of data, are more susceptible to electromagnetic interference than physically shielded wired links. Critical care settings with a high density of electronic medical devices represent a harsh environment for short-range wireless technologies. Since short-range wireless radios initially are not developed for medical use, clinical trials to study the robustness and stability of short-range wireless technologies in patient monitoring were the basis of this thesis. In critical care monitoring systems medical sensors sample data intermittently or as continuous data, and data streams are displayed on monitors as real-time waveforms or time-series of data. Announcement from Faculty of Medicine, University of Oslo here
Professor Erik Fosse, Head of The Intervention Centre, Oslo University Hospital, is awarded the University of Oslo Innovation Prize 2015. Prof.Fosse received the prize for his valuable contribution to the field of medicine and health services at a ceremony which took place September 2nd 2015. University of Oslo Innovation Prize short lectures here.
The Norwegian Research Council of Norway allocated funding for evaluation of the LuerJack®, single handed syringe concept, through the Regional Research, Design and Innovation (VRI) program. The Testbed at The Intervention Centre received an assignment from ConceptoMed to evaluate the clinical feasibility of the Luer Jack®. Focus group sessions with clinical specialists at Oslo University Hospital were conducted to gain feedback on the concept from potential users as well as to identify relevant user groups and clinical applications for further concept development. Results of the study show that the Luer Jack® may contribute to quality improvement of clinical procedures. The safety mechanism integrated to the device promotes an effective non-touch technique, potentially facilitating improved anti-septic and aseptic field management. The Luer Jack® as a safety syringe can reduce the risk of needle stick injury and health care acquired infection. The findings from the current study demonstrate the importance o user-centered design to mitigate risk and meet the challenges of healthcare services of the future. The Intervention Centre has established a Testbed for medical devices that serves as a platform where new early stage and pre-market diagnostic and therapeutic equipment and devices can be evaluated. The current project provides an example of successful collaboration between healthcare providers and companies developing new medical products and services. Demonstration of Luer Jack here
Visit the web page of the MedTech Test Facility at Oslo University Hospital. The Test Facility is a professional gateway for companies with new high tech equipment in need for early phase clinical trials.
English is the main language in this web portal. Some information is also available in Norwegian
The Interventional Centre receives donations to medical research. Questions related to donations can be sent to head of department professor Erik Fosse.
Author: Erik Fosse
Publisher: Det Medisinske Selskap 2007
Price: 180 kr
Also sold in Bookstores